Mike Hildebrand
Professor
Faculty of Science
Department of Neuroscience
Clusters:
Health
Ottawa, Ontario
Mike.Hildebrand@carleton.ca
Mobile:
(613) 255-3243
Office:
(613) 520-2600 ext. 3306
Expert In
Bio/Research
Hildebrand completed his PhD in Molecular and Cellular Neuroscience in 2008 at the University of British Columbia. He did an industrial postdoctoral fellowship at Zalicus Pharmaceuticals in Vancouver from 2008 to 2010 followed by an academic postdoctoral fellowship at the Sick Kids Hospital in To...
Click to Expand >>
Click to Expand >>
Bio/Research
Hildebrand completed his PhD in Molecular and Cellular Neuroscience in 2008 at the University of British Columbia. He did an industrial postdoctoral fellowship at Zalicus Pharmaceuticals in Vancouver from 2008 to 2010 followed by an academic postdoctoral fellowship at the Sick Kids Hospital in Toronto from 2010 to 2013. Dr. Hildebrand began his research lab at Carleton University in 2013.
The Hildebrand Lab investigates spinal mechanisms of pain processing. They use a combination of molecular, pharmacological, electrophysiological, and behavioural approaches to identify the molecular pathways that regulate pain sensation in both acute and chronic pain states. The goals of the lab include:
Exploring spinal networks in both rodent and human tissue models of pain bridge the translational divide between basic science research and the unmet clinical needs of chronic pain patients
Identifying new molecular targets and potential treatment approaches for managing chronic pain
Click to Shrink <<
The Hildebrand Lab investigates spinal mechanisms of pain processing. They use a combination of molecular, pharmacological, electrophysiological, and behavioural approaches to identify the molecular pathways that regulate pain sensation in both acute and chronic pain states. The goals of the lab include:
Exploring spinal networks in both rodent and human tissue models of pain bridge the translational divide between basic science research and the unmet clinical needs of chronic pain patients
Identifying new molecular targets and potential treatment approaches for managing chronic pain
Click to Shrink <<